Literature DB >> 28360202

Preventing acquisition of HIV is the only path to an AIDS-free generation.

Lawrence Corey1,2,3, Glenda E Gray4,5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28360202      PMCID： PMC5393193          DOI： 10.1073/pnas.1703236114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  Effectiveness of UNAIDS targets and HIV vaccination across 127 countries.

Authors:  Jan Medlock; Abhishek Pandey; Alyssa S Parpia; Amber Tang; Laura A Skrip; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

2.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

3.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

4.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

5.  Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.

Authors:  J E Ledgerwood; E E Coates; G Yamshchikov; J G Saunders; L Holman; M E Enama; A DeZure; R M Lynch; I Gordon; S Plummer; C S Hendel; A Pegu; M Conan-Cibotti; S Sitar; R T Bailer; S Narpala; A McDermott; M Louder; S O'Dell; S Mohan; J P Pandey; R M Schwartz; Z Hu; R A Koup; E Capparelli; J R Mascola; B S Graham
Journal:  Clin Exp Immunol       Date:  2015-09-24       Impact factor: 4.330

6.  Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.

Authors:  M Gisslén; V Svedhem; L Lindborg; L Flamholc; H Norrgren; S Wendahl; M Axelsson; A Sönnerborg
Journal:  HIV Med       Date:  2016-08-18       Impact factor: 3.180

7.  Potential future impact of a partially effective HIV vaccine in a southern African setting.

Authors:  Andrew N Phillips; Valentina Cambiano; Fumiyo Nakagawa; Deborah Ford; Jens D Lundgren; Edith Roset-Bahmanyar; François Roman; Thierry Van Effelterre
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

8.  Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.

Authors:  Dobromir Dimitrov; James G Kublin; Scott Ramsey; Lawrence Corey
Journal:  EBioMedicine       Date:  2015-11-05       Impact factor: 8.143

9.  Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012.

Authors:  Nishila Moodley; Glenda Gray; Melanie Bertram
Journal:  BMC Public Health       Date:  2016-04-14       Impact factor: 3.295
  9 in total
  7 in total

1.  Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.

Authors:  Lue Ping Zhao; Andrew Fiore-Gartland; Lindsay N Carpp; Kristen W Cohen; Nadine Rouphael; Llewellyn Fleurs; One Dintwe; Michael Zhao; Zoe Moodie; Youyi Fong; Nigel Garrett; Ying Huang; Craig Innes; Holly E Janes; Erica Lazarus; Nelson L Michael; Sorachai Nitayaphan; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Merlin L Robb; Stephen C De Rosa; Lawrence Corey; Glenda E Gray; Kelly E Seaton; Nicole L Yates; M Juliana McElrath; Nicole Frahm; Georgia D Tomaras; Peter B Gilbert
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

Review 2.  Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Authors:  Linda-Gail Bekker; George Alleyne; Stefan Baral; Javier Cepeda; Demetre Daskalakis; David Dowdy; Mark Dybul; Serge Eholie; Kene Esom; Geoff Garnett; Anna Grimsrud; James Hakim; Diane Havlir; Michael T Isbell; Leigh Johnson; Adeeba Kamarulzaman; Parastu Kasaie; Michel Kazatchkine; Nduku Kilonzo; Michael Klag; Marina Klein; Sharon R Lewin; Chewe Luo; Keletso Makofane; Natasha K Martin; Kenneth Mayer; Gregorio Millett; Ntobeko Ntusi; Loyce Pace; Carey Pike; Peter Piot; Anton Pozniak; Thomas C Quinn; Jurgen Rockstroh; Jirair Ratevosian; Owen Ryan; Serra Sippel; Bruno Spire; Agnes Soucat; Ann Starrs; Steffanie A Strathdee; Nicholas Thomson; Stefano Vella; Mauro Schechter; Peter Vickerman; Brian Weir; Chris Beyrer
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

Review 3.  Prospects for passive immunity to prevent HIV infection.

Authors:  Lynn Morris; Nonhlanhla N Mkhize
Journal:  PLoS Med       Date:  2017-11-14       Impact factor: 11.069

4.  Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.

Authors:  Christian Selinger; Anna Bershteyn; Dobromir T Dimitrov; Blythe J S Adamson; Paul Revill; Timothy B Hallett; Andrew N Phillips; Linda-Gail Bekker; Helen Rees; Glenda Gray
Journal:  Vaccine       Date:  2019-03-16       Impact factor: 3.641

5.  Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design.

Authors:  Marc H V Van Regenmortel
Journal:  Front Immunol       Date:  2018-01-12       Impact factor: 7.561

Review 6.  Modelling microbial infection to address global health challenges.

Authors:  Meagan C Fitzpatrick; Chris T Bauch; Jeffrey P Townsend; Alison P Galvani
Journal:  Nat Microbiol       Date:  2019-09-20       Impact factor: 17.745

7.  Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.

Authors:  Daniel B Reeves; Yunda Huang; Elizabeth R Duke; Bryan T Mayer; E Fabian Cardozo-Ojeda; Florencia A Boshier; David A Swan; Morgane Rolland; Merlin L Robb; John R Mascola; Myron S Cohen; Lawrence Corey; Peter B Gilbert; Joshua T Schiffer
Journal:  PLoS Comput Biol       Date:  2020-02-21       Impact factor: 4.779
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.